Conjunctivitis, keratitis and infections of periorbital structures

Infectious Diseases: Third Edition

Volumn 1, Issue , 2010, Pages 177-184

  Drancourt, Michel ^a   Herbert, Luke ^b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85018240154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04579-7.00015-0     Document Type: Chapter

References (65)

1. Rietveld R.P., ter Riet G., Bindels P.J., Schellevis F.G., van Weert H.C. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice. BMC Fam Pract 2007, 8:54.
2. Wright H.R., Turner A., Taylor H.R. Trachoma. Lancet 2008, 371:1945-1954.
3. Laga M., Meheus A., Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989, 67:471-477.
4. Talley A.R., Garcia-Ferrer F., Laycock K.A., et al. Comparative diagnosis of neonatal chlamydial conjunctivitis by polymerase chain reaction and McCoy cell culture. Am J Ophthalmol 1994, 117:50-57.
5. Beatty W.L., Byrne G.I., Morrison R.P. Repeated and persistent infection with chlamydia and the development of chronic inflammation and disease. Trends Microbiol 1994, 2:94-98.
6. Liesegang T.J. Bacterial keratitis. Infect Dis Clin N Am 1992, 6:815-829.
7. Limberg M.B. A review of bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol 1991, 112:2-9.
8. Haller E.M., Auer-Grumbach P., Stuenzner D., et al. Detection of antichlamydial antibodies in tears: a diagnostic aid?. Ophthalmology 1997, 104:125-130.
9. Isenberg S.J., Apt L., Yoshimori R., Leake R.D., Rich R. Povidone-iodine for ophthalmia neonatorum prophylaxis. Am J Ophthalmol 1994, 118:701-706.
10. Munoz B., West S. Trachoma: the forgotten cause of blindness. Epidemiol Rev 1997, 19:205-217.
11. Laga M., Naamara W., Brunham R.C., et al. Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl J Med 1986, 315:1382-1385.
12. Armstrong M. The laboratory investigation of infective keratitis. Br J Biomed Sci 1994, 51:65-72.
13. Liesegang T.J., Forster R.K. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980, 90:38-47.
14. Jones D.B. Polymicrobial keratitis. Trans Am Ophthalmol Soc 1981, 79:153-156.
15. Tabbara K.F. Tuberculosis. Curr Opin Ophthalmol 2007, 18:493-501.
16. Lalitha P., Tiwari M., Prajna N.V., Gilpin C., Prakash K., Srinivasan M. Nocardia keratitis: species, drug sensitivities, and clinical correlation. Cornea 2007, 26:255-259.
17. Norn M.S. Dendritic (herpetic) keratitis. I. Incidence - seasonal variations - recurrence rate - visual impairment - therapy. Acta Ophthalmol (Copenh) 1970, 48:91-107.
18. Pepose J.S. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol 1991, 35:345-352.
19. Chung P.C., Lin K.K., Song H.S., Ku W.C., Huang S.C., Sun C.C. Alport syndrome with recurrent herpes simplex virus keratitis. Cornea 2007, 26:1279-1281.
20. Fraser N.W., Spivack J.G., Wroblewska Z., et al. A review of the molecular mechanism of HSV-1 latency. Curr Eye Res 1991, 10(Suppl.):1-13.
21. Parks D.J., Abrams D.A., Sarfarazi F.A., Katz H.R. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993, 115:471-477.
22. Hyndiuk R.A., Eiferman R.A., Caldwell D.R., et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 1996, 103:1854-1862.
23. Goldstein M.H., Kowalski R.P., Gordon J. Emerging fluoroquinolone resistance in bacterial keratitis. A 5-year review. Ophthalmology 1999, 106:1313-1318.
24. Allan B.D., Dart J.K. Strategies for the management of microbial keratitis. Br J Ophthalmol 1995, 79:777-786.
25. Grant D.M. Acyclovir (Zovirax) ophthalmic ointment: a review of clinical tolerance. Curr Eye Res 1987, 6:231-235.
26. Herpetic Eye Disease Study Group. N Engl J Med 1998, 339:300-306. Acyclovir for the prevention of recurrent herpes simplex virus eye disease.
27. Wilhelmus K.R., Dawson C.R., Barron B.A., et al. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br J Ophthalmol 1996, 80:969-972.
28. Cobo M. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir. Am J Med 1988, 85:90-93.
29. Wood M.J., Johnson R.W., McKendrick M.J., et al. A randomised trial of acyclovir for 7 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994, 330:896-900.
30. Chern K.C., Conrad D., Holland G.N., et al. Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1998, 116:1011-1017.
31. Bottone E.J., Cho K.W. Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient's contact lens care system. Cornea 2005, 24:356-358.
32. Ng A.S., Lau W.W., Yu D.K., Wong C.C., Chan C.W. Clinical features and outcomes of Fusarium keratitis associated with contact lens wear. Eye Contact Lens 2008, 34:113-116.
33. Keay L., Edwards K., Brian G., Stapleton F. Surveillance of contact lens related microbial keratitis in Australia and New Zealand: multi-source case-capture and cost-effectiveness. Ophthalmic Epidemiol 2007, 14:343-350.
34. Liesegang T.J. Contact lens-related microbial keratitis: part I: epidemiology. Cornea 1997, 16:125-131.
35. Dart J.K. The epidemiology of contact lens related diseases in the United Kingdom. CLAOJ 1993, 19:241-246.
36. Watt K.G., Swarbrick H.A. Trends in microbial keratitis associated with orthokeratology. Eye Contact Lens 2007, 33:373-377.
37. Tuli S.S., Iyer S.A., Driebe W.T. Fungal keratitis and contact lenses: an old enemy unrecognized or a new nemesis on the block?. Eye Contact Lens 2007, 33:415-417.
38. Gorscak J.J., Ayres B.D., Bhagat N., et al. An outbreak of Fusarium keratitis associated with contact lens use in the northeastern United States. Cornea 2007, 26:1187-1194.
39. Hu S., Fan V.C., Koonapareddy C., Du T.T., Asbell P.A. Contact lens-related Fusarium infection: case series experience in New York City and review of fungal keratitis. Eye Contact Lens 2007, 33:322-328.
40. Bacon A.S., Frazer D.G., Dart J.K., Matheson M., Ficker L.A., Wright P. A review of 72 consecutive cases of acanthamoeba keratitis, 1984-1992. Eye 1993, 7:719-725.
41. Illingworth C.D., Cook S.D. Acanthamoeba keratitis. Surv Ophthalmol 1998, 42:493-508.
42. McLeod S.D., Kolahdouz-Isfahani A., Rostamian K., Flowers C.W., Lee P.P., McDonnell P.J. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology 1996, 103:23-28.
43. Walker C.W. Acanthamoeba: ecology, pathogenicity and laboratory detection. Br J Biomed Sci 1996, 53:146-151.
44. Parmar D.N., Awwad S.T., Petroll W.M., Bowman R.W., McCulley J.P., Cavanagh H.D. Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology 2006, 113:538-547.
45. Visvesvara G.S., Moura H., Schuster F.L. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 2007, 50:1-26.
46. Moura H., Ospina M., Woolfitt A.R., Barr J.R., Visvesvara G.S. Analysis of four human microsporidian isolates by MALDI-TOF mass spectrometry. J Eukaryot Microbiol 2003, 50:156-163.
47. Rivière D., Szczebara F.M., Berjeaud J.M., Frère J., Héchard Y. Development of a real-time PCR assay for quantification of Acanthamoeba trophozoites and cysts. J Microbiol Methods 2006, 64:78-83.
48. Qvarnstrom Y., Visvesvara G.S., Sriram R., da Silva A.J. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol 2006, 44:3589-3595.
49. Sharma S., Taneja M., Gupta R., et al. Comparison of clinical and microbiological profiles in smear-positive and smear-negative cases of suspected microbial keratitis. Indian J Ophthalmol 2007, 55:21-25.
50. Baker D.A., Pavan-Langston D., Gonik B., et al. Multicenter clinical evaluation of the Du Pont Herpchek HSV ELISA, a new rapid diagnostic test for the direct detection of herpes simplex virus. Adv Exp Med Biol 1990, 263:71-76.
51. Duguid I.G., Dart J.K., Morlet N., et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997, 104:1587-1592.
52. O'Day D.M. Selection of appropriate antifungal therapy. Cornea 1987, 6:238-245.
53. Mohan M., Panda A., Gupta S.K. Management of human keratomycosis with miconazole. Aust N Z J Ophthalmol 1989, 17:295-297.
54. Rahman M.R., Johnson G.J., Husain R., Howlader S.A., Minassian D.C. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol 1998, 82:919-925.
55. Moore M.B. Acanthamoeba keratitis and contact lens wear: the patient is at fault. Cornea 1990, 9(Suppl.1):33-35.
56. Butcko V., McMahon T.T., Joslin C.E., Jones L. Microbial keratitis and the role of rub and rinsing. Eye Contact Lens 2007, 33:421-423.
57. Kailasanathan A., Anderson D.F. Infectious crystalline keratopathy caused by Gemella haemolysans. Cornea 2007, 26:643-644.
58. Wagoner M.D., Al-Ghamdi A.H., Al-Rajhi A.A. Bacterial keratitis after primary pediatric penetrating keratoplasty. Am J Ophthalmol 2007, 143:1045-1047.
59. Semoun O., Bourcier T., Dupas B., et al. Early bacterial keratitis after presbyopic LASIK. Cornea 2008, 27:114-116.
60. Solomon R., Donnenfeld E.D., Perry H.D., et al. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. Am J Ophthalmol 2007, 143:629-634.
61. Vajpayee R.B., Sharma N., Sinha R., Agarwal T., Singhvi A. Infectious keratitis following keratoplasty. Surv Ophthalmol 2007, 52:1-12.
62. Hamada N., Gotoh K., Hara K., et al. Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses. J Hosp Infect 2008, 68:262-268.
63. Lieger O., Oho S., Clemetson I.A., Arnold H., Iisuka T. Orbital manifestation of Whipple's disease: an atypical case. J Cranio-Maxillofacial Surg 2007, 35:393-396.
64. Gutowski W.M., Mulbury P.E., Hengerer A.S., Kido D.K. The role of CT scans in managing the orbital complications of ethmoiditis. Int J Pediatr Otorhinolaryngol 1988, 15:117-128.
65. Harris G.J. Subperiosteal abscess of the orbit. Age as a factor in the bacteriology and response to treatment. Ophthalmology 1994, 101:585-595.